Eli Lilly LLY0.87%increase; green up pointing triangle continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters the drugmaker’s blood-cancer ...

Eli Lilly (LLY) has agreed to acquire biopharmaceutical company Ajax Therapeutics for up to $2.3B in cash, inclusive of an upfront payment and subsequent payments upon the achievement of certain ...

April 27 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up ‌to $2.3 billion in cash, as the U.S. drugmaker looks to ...

Is maximizing AI usage inside a company always a good thing? That’s the question startups, investors and big corporations were asking after an internal dashboard at Meta Platforms went viral for ...

Tokens are the basic unit of AI usage, but the consumption is becoming a distorted metric. Incentivizing maximum use of tokens only measures what an engineer spends on AI instead of what they produce ...

Forbes contributors publish independent expert analyses and insights. I write about how fintech is disrupting the financial industry in Asia. Stablecoins are moving beyond crypto and becoming the ...

Farran Powell is the managing editor of investing at Forbes Advisor. She was previously the assistant managing editor of investing at U.S. News & World Report. Her work has appeared in numerous ...

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Doretha Clemons, Ph.D., MBA, PMP, has been a ...

Allie is a financial writer and editor with over five years of experience. An investment banker turned journalist, she has previously reported on cryptocurrency for MT Newswires and edited ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.